Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes

Diabetologia. 2009 Oct;52(10):2244. doi: 10.1007/s00125-009-1495-4. Epub 2009 Aug 19.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Chelating Agents / therapeutic use*
  • Copper / metabolism*
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Angiopathies / drug therapy
  • Diabetic Angiopathies / etiology
  • Female
  • Humans
  • Hypertrophy, Left Ventricular / drug therapy*
  • Hypertrophy, Left Ventricular / etiology*
  • Hypertrophy, Left Ventricular / physiopathology
  • Male
  • Middle Aged

Substances

  • Chelating Agents
  • Copper